GlassScriptPhysician profile
Vinaya Potluri
NPI 1881647493
$2,584.27
in general payments reported to CMS, 2019-2025
36 companies · $724 in 2025
The $724 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $310 · 2020: $194 · 2021: $325 · 2022: $105 · 2023: $637 · 2024: $289 · 2025: $724.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,649.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $273.54 | 2021-2023 | Enhertu |
| Amgen INC. | $186.40 | 2023-2025 | Xgeva, Vectibix, Nplate |
| Celgene Corporation | $179.03 | 2022-2025 | Reblozyl, Pomalyst |
| Astrazeneca Pharmaceuticals LP | $167.12 | 2019-2025 | Datroway, Calquence |
| Sirtex Medical INC | $146.56 | 2025 | Sir-Spheres Microspheres |
| Puma Biotechnology, INC. | $135.93 | 2021 | |
| Pfizer INC. | $132.99 | 2019-2024 | |
| Exelixis INC. | $119.01 | 2019 | |
| Astellas Pharma US INC | $118.04 | 2020 | |
| Abbvie INC. | $107.34 | 2023-2025 | |
| Glaxosmithkline, LLC. | $102.89 | 2022-2025 | Ojjaara, Blenrep, Jemperli |
| Caris Mpi, INC. | $101.20 | 2025 | Mi Cancer Seek |
| Janssen Biotech, INC. | $98.32 | 2019-2024 | Tecvayli |
| E.R. Squibb & Sons, L.L.C. | $83.78 | 2022-2025 | |
| Genzyme Corporation | $76.95 | 2019-2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Array Biopharma INC | $70.12 | 2024-2025 | Mektovi, Braftovi, Lorbrena |
| Merck Sharp & Dohme LLC | $62.79 | 2024-2025 | Keytruda |
| Servier Pharmaceuticals LLC | $41.38 | 2025 | |
| Myriad Genetic Laboratories, INC. | $40.77 | 2021 | |
| Novartis Pharmaceuticals Corporation | $35.20 | 2020-2024 | |
| Kite Pharma, INC. | $31.98 | 2023 | |
| Janssen Pharmaceuticals, INC | $26.80 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $25.84 | 2023 | Epkinly, Imbruvica |
| Beigene USA, INC. | $24.61 | 2020 | |
| Agios Pharmaceuticals, INC. | $21.11 | 2023 | Pyrukynd |
| Beone Medicines USA, INC. | $21.00 | 2025 | Brukinsa |
| Recordati_rare_diseases_inc. | $20.22 | 2025 | Sylvant |
| Genentech USA, INC. | $18.86 | 2019 | |
| Eisai INC. | $18.48 | 2023 | |
| Seagen INC. | $17.24 | 2023 | Padcev |
| Emd Serono, INC. | $14.82 | 2019 | |
| Tempus Ai, INC | $14.30 | 2024 | |
| Secura Bio, INC. | $14.19 | 2023 | Copiktra |
| Acrotech Biopharma INC. | $11.97 | 2021 | |
| Gilead Sciences, INC. | $11.92 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinaya Potluri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.